Immunome (IMNM)Chief Technology Officer bought ~$104K
Philip Tsai, Chief Technology Officer at Immunome, bought ~$104K of Immunome shares.
- ~$104K
- Approx. value · 12K sh @ $8.42
- 33K
- Holds after · shares reported
- Traded
- Mar 24, 2025
- Filed
- Mar 25, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 31, 2025InsiderCEO purchased ~$1.16M of IMNM shares in the open market
- Mar 24, 2025 · this disclosureInsiderOfficer purchased ~$104K of IMNM shares in the open market
What came next
- Mar 24, 2025InsiderDirector purchased ~$57K of IMNM shares in the open market
- Mar 25, 2025InsiderDirector purchased ~$61K of IMNM shares in the open market
- Mar 26, 2025InsiderCEO purchased ~$999K of IMNM shares in the open market
- Jun 3, 2025InsiderDirector purchased ~$47K of IMNM shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Immunome
For Immunome, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its IMNM page.
Other recent filings by Philip Tsai, Chief Technology Officer
The full history of Philip Tsai, Chief Technology Officer is on the profile page.
How this filing works
Other disclosures at Immunome
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 4Jun 4, 2025
- SEC Form 4Mar 26, 2025
- SEC Form 4Mar 26, 2025
Everything OQRO holds on this company is on its IMNM page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data